Search - tctmd.com

Displaying 1 - 20 of 32

Sort: Relevancy | Date

News Daily News

Plants and Animals: Protein’s Link to Mortality and Cardiovascular Death Depends on Its Source

Michael H. Wilson

August 04, 2016

News Daily News

Bad Breaths: Atherosclerosis, Adverse Cardiac Outcomes Linked to Air Pollution

Yael L. Maxwell

August 03, 2016

News Daily News

Time for Niacin to Be ‘Relegated to Medical History’ as HPS2-THRIVE Analysis Confirms Drug’s Failings

Michael O'Riordan

July 12, 2016

News Daily News

CABG Shows Survival Advantage Over PCI in Nondiabetic Patients With Multivessel Disease

L.A. McKeown

June 29, 2016

News Daily News

Media Scrutiny Over Risks and Benefits of Statins Impacts Patient Use

Michael O'Riordan

June 28, 2016

News Daily News

Stimulant Drug Methylphenidate, Used for ADHD, Linked With Increased Risks of Arrhythmia, MI

Michael O'Riordan

June 01, 2016

News Daily News

Reductions in Stroke Observed With BP Less Than 140 mm Hg, Fueling Support for Lower Threshold

Michael O'Riordan

February 02, 2016

News Daily News

PCI for Cardiogenic Shock: Mortality Has Increased, but So Has Patient Risk

Yael L. Maxwell

January 20, 2016

News Conference News TCT 2015

Nordic-Baltic Bifurcation III: Kissing Balloon Dilatation Does Not Reduce MACE at 5 Years

October 16, 2015

News Daily News

Registry Charts Trends in Mechanical Circulatory Support During PCI

L.A. McKeown

September 14, 2015

News Daily News

Novel Antisense Inhibitor Cuts High Triglyceride Levels

August 13, 2015

News Daily News

Zero Calcium Score Provides 15-Year Mortality ‘Warranty’ for Asymptomatic Patients

August 06, 2015

News Daily News

Catheter-Delivered Gene Therapy Yields Positive Signal in Advanced Heart Failure

June 23, 2015

News Daily News

In-Stent Neoatherosclerosis Tied to Plaque Progression in Untreated Arteries

June 16, 2015

News Industry News

Juventas Therapeutics Presents New 12-Month Data Demonstrating Single Administration of JVS-100 Improves Cardiac and Clinical Status in Patients with Severe Ischemic Heart Failure One Year After Treat

May 26, 2015

News Industry News

CVRx® Barostim Therapy® for Heart Failure Clinical Trial Results Presented in the Late-Breaking Clinical Trial Session of the Heart Rhythm Society 2015 Annual Conference

May 26, 2015

News Daily News

ISAR-TRIPLE Published: No Net Gain for 6 Weeks vs 6 Months of Triple Therapy

April 29, 2015

News Daily News

Analysis of SYNTAX Patients Documents Underuse of OMT

L.A. McKeown

March 05, 2015

News Daily News

Vorapaxar Effective for Secondary Prevention in Diabetic Patients With Prior MI

L.A. McKeown

February 22, 2015

Advertisement

Plants and Animals: Protein’s Link to Mortality and Cardiovascular Death Depends on Its Source

Bad Breaths: Atherosclerosis, Adverse Cardiac Outcomes Linked to Air Pollution

Time for Niacin to Be ‘Relegated to Medical History’ as HPS2-THRIVE Analysis Confirms Drug’s Failings

CABG Shows Survival Advantage Over PCI in Nondiabetic Patients With Multivessel Disease

Media Scrutiny Over Risks and Benefits of Statins Impacts Patient Use

Stimulant Drug Methylphenidate, Used for ADHD, Linked With Increased Risks of Arrhythmia, MI

Reductions in Stroke Observed With BP Less Than 140 mm Hg, Fueling Support for Lower Threshold

PCI for Cardiogenic Shock: Mortality Has Increased, but So Has Patient Risk

Nordic-Baltic Bifurcation III: Kissing Balloon Dilatation Does Not Reduce MACE at 5 Years

Registry Charts Trends in Mechanical Circulatory Support During PCI

Novel Antisense Inhibitor Cuts High Triglyceride Levels

Zero Calcium Score Provides 15-Year Mortality ‘Warranty’ for Asymptomatic Patients

Catheter-Delivered Gene Therapy Yields Positive Signal in Advanced Heart Failure

In-Stent Neoatherosclerosis Tied to Plaque Progression in Untreated Arteries

Juventas Therapeutics Presents New 12-Month Data Demonstrating Single Administration of JVS-100 Improves Cardiac and Clinical Status in Patients with Severe Ischemic Heart Failure One Year After Treat

CVRx® Barostim Therapy® for Heart Failure Clinical Trial Results Presented in the Late-Breaking Clinical Trial Session of the Heart Rhythm Society 2015 Annual Conference

ISAR-TRIPLE Published: No Net Gain for 6 Weeks vs 6 Months of Triple Therapy

Analysis of SYNTAX Patients Documents Underuse of OMT

Vorapaxar Effective for Secondary Prevention in Diabetic Patients With Prior MI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content